No human clinical trial has demonstrated that fasting shrinks existing arterial plaque. The honest state of the science is that a handful of promising animal experiments and a growing understanding of how fasting changes inflammation, blood lipids, and blood vessel health suggest it could help, but that evidence sits alongside mouse studies showing the opposite effect and epidemiological signals that very short eating windows might increase cardiovascular death. The gap between “plausible biological mechanism” and “proven therapy” remains wide on this question.
What Animal Studies Actually Show
The most direct evidence for plaque regression comes from a mouse study published in Cell Communication and Signaling. Researchers found that intermittent fasting reduced plaque size compared to both freely fed mice and a baseline group, and the remaining plaques showed structural features associated with greater stability, all without additional lipid lowering at the study’s endpoint.1Cell Communication and Signaling. Intermittent fasting promotes plaque regression and activates the BMAL1–MERTK efferocytosis axis The mechanism appeared to involve a process called efferocytosis, where immune cells clear dead and dying cells from within plaque. Fasting activated a signaling pathway involving the receptor MerTK, which is known to be critical for that cleanup. Separate research in atherosclerosis-prone mice has shown that boosting MerTK expression leads to smaller necrotic cores inside plaques and thicker protective caps over them.2JCI Insight. CAMKIIγ suppresses an efferocytosis pathway in macrophages and promotes atherosclerotic plaque necrosis
But there is a sharp counterpoint. A study in Life Metabolism using a different atherosclerosis-prone mouse model found that alternate-day fasting actually made plaques worse. After eight weeks, the fasting mice had lesion areas roughly 1.3 to 1.5 times larger than freely fed controls. When the researchers tested the same protocol on mice with more advanced, established plaques, the results were similar: plaque grew faster with fasting.3Life Metabolism. Alternate day fasting aggravates atherosclerosis through the suppression of hepatic ATF3 in Apoe−/− mice The apparent mechanism involved suppression of a liver protein (ATF3) that normally helps manage cholesterol. These two studies used different mouse strains, different fasting schedules, and different diet compositions, which likely explains the conflicting outcomes. The takeaway is that “fasting” is not one uniform stimulus; the details of the protocol seem to matter enormously.
What Fasting Does to Blood Lipids
Plaque formation is driven in part by LDL cholesterol infiltrating artery walls, so anything that lowers LDL should, in theory, slow plaque growth. A review of the evidence on intermittent fasting and lipid profiles concluded that both normal-calorie and reduced-calorie versions of intermittent fasting can lower total cholesterol, LDL cholesterol, and triglycerides while raising HDL in men and women across a range of body types.4PubMed. Impact of intermittent fasting on the lipid profile: Assessment associated with diet and weight loss Those are exactly the directional changes you want for arterial health.
However, acute, prolonged fasting tells a different story. When ten healthy, non-obese adults fasted completely for seven days, their total cholesterol jumped by about 37 percent and their LDL cholesterol surged by roughly 66 percent.5PubMed. Fasting increases serum total cholesterol, LDL cholesterol and apolipoprotein B in healthy, nonobese humans That is a dramatic spike in the very particles that seed plaque. The effect is thought to result from the body mobilizing fat stores for fuel, flooding the bloodstream with lipids in the process. This underscores an important distinction: intermittent fasting protocols of twelve to twenty-four hours behave very differently from multi-day starvation, and lumping them together under “fasting” can be misleading.
Fasting and Vascular Inflammation
Plaque is not just a cholesterol storage problem. Chronic inflammation inside the artery wall is what makes plaques grow, become unstable, and eventually rupture, which is the event that triggers most heart attacks. A significant line of research links fasting to suppression of a key inflammatory engine called the NLRP3 inflammasome, a protein complex in immune cells that drives the production of the inflammatory signal IL-1β.
A study in human volunteers found that fasting increased levels of the protein SIRT3 in white blood cells, which in turn activated an antioxidant enzyme (SOD2) inside mitochondria. The net effect was a reduction in the reactive oxygen species that trigger the NLRP3 inflammasome. When cells were engineered to lack SIRT3, fasting’s anti-inflammatory advantage disappeared, confirming the link.6JCI Insight. Fasting and refeeding differentially regulate NLRP3 inflammasome activation in human subjects A complementary study identified another mechanism: arachidonic acid, a fatty acid that rises in plasma during fasting, directly inhibited the NLRP3-driven production of IL-1β in mouse immune cells, even at low concentrations.7Cell Reports. Arachidonic acid inhibits the NLRP3 inflammasome and is a metabolic regulator of fasting-induced suppression of inflammation
A narrative review synthesizing multiple lines of evidence concluded that there is convincing support for the idea that ketogenic interventions, which share metabolic ground with fasting, reduce NLRP3 inflammasome activation, likely through several interacting mechanisms rather than a single switch.8PubMed Central. Impact of fasting & ketogenic interventions on the NLRP3 inflammasome: A narrative review The review also cautioned that it is difficult to isolate the role of any single molecule like the ketone body BHB from the constellation of other metabolic shifts that accompany fasting, including low insulin levels, stable glucose, and negative energy balance.
Protecting the Blood Vessel Lining
The endothelium, the single-cell layer that lines every artery, is ground zero for plaque formation. When it is damaged or inflamed, it becomes sticky and permeable to LDL particles. Conversely, healthy endothelial function keeps arteries flexible and resistant to plaque. Clinical evidence indicates that time-restricted eating improves flow-mediated dilation, a standard measure of endothelial function, in patients with metabolic syndrome.9Science Bulletin. Intermittent fasting and cardiovascular health: a circadian rhythm-based approach
Part of this benefit may come from beta-hydroxybutyrate (BHB), the main ketone body the liver produces during fasting. In lab experiments on human endothelial cells exposed to inflammatory conditions, BHB reduced mitochondrial production of damaging superoxide and switched on antioxidant gene expression. The treated cells showed improved baseline oxygen consumption and greater respiratory reserve, signs of healthier mitochondria.10PubMed Central. Effect of Ketone Body β-Hydroxybutyrate to Attenuate Inflammation-Induced Mitochondrial Oxidative Stress in Vascular Endothelial Cells Separately, BHB protected endothelial cells from damage caused by low-glucose conditions, preserving the expression of eNOS, the enzyme that produces nitric oxide, the molecule responsible for keeping arteries relaxed and open.11PubMed Central. Protective effect of 3-hydroxybutyrate against endoplasmic reticulum stress-associated vascular endothelial cell damage induced by low glucose exposure
These cell-culture findings are consistent with the clinical observation that endothelial function improves with fasting, but they do not prove plaque regression. Healthier endothelium plausibly slows new plaque development and may help stabilize existing plaque, yet that remains inference rather than demonstrated fact in humans.
Is Fasting Better Than Just Eating Less?
A common question is whether intermittent fasting offers cardiovascular advantages beyond simple calorie reduction. The answer from current evidence is: modestly, and in specific areas. A twelve-week trial comparing 5:2 intermittent fasting with standard calorie restriction in adults with overweight or obesity found that the fasting group ended up with lower systolic blood pressure, lower pulse pressure, and lower thirty-year Framingham cardiovascular risk scores, while other metabolic markers like glucose and lipids were similar between groups.12Scientific Reports. Comparative effects of intermittent fasting and calorie restriction on cardiovascular health in adults with overweight or obesity
A systematic review and meta-analysis that pooled randomized trials with matched calorie intakes found that intermittent fasting produced greater short-term reductions in fat mass and the inflammatory marker IL-6, plus better long-term improvements in waist circumference, fasting insulin, and insulin resistance. The calorie-restriction groups, however, scored better on hunger, fatigue, and triglycerides. The authors concluded that intermittent fasting may be an effective alternative but is not clearly superior overall.13PubMed. Is isocaloric intermittent fasting superior to calorie restriction? A systematic review and meta-analysis of RCTs A separate systematic review reached a similar conclusion: with matched energy intake, the two approaches produced comparable effects on weight and chronic disease risk factors, with very limited evidence hinting at an advantage for fasting on fat loss and insulin sensitivity.14Journal of the Academy of Nutrition and Dietetics. Effects of Isocaloric Intermittent Fasting Versus Daily Caloric Restriction on Weight Loss and Metabolic Risk Factors in Adults with Overweight and Obesity: A Systematic Review
None of these trials measured arterial plaque directly. They tracked the risk factors, blood pressure, lipids, insulin resistance, and inflammation, that contribute to plaque formation. So fasting’s edge over calorie restriction for plaque specifically remains unknown.
When You Eat Might Matter More Than How Long You Fast
An emerging theme in the research is that aligning your eating window with your body’s circadian rhythm amplifies the benefits. In a crossover trial in men with prediabetes, restricting eating to a six-hour window ending in the early afternoon lowered systolic blood pressure by about 11 mmHg and diastolic by about 10 mmHg compared to a normal eating schedule, and it improved insulin sensitivity and reduced oxidative stress, all without any weight loss.15Cell Metabolism. Early Time-Restricted Feeding Improves Insulin Sensitivity, Blood Pressure, and Oxidative Stress even without Weight Loss in Men with Prediabetes Those blood pressure changes are clinically meaningful and on par with what some medications achieve.
A meta-analysis comparing early versus later time-restricted eating found that eating earlier in the day produced significantly greater improvements in insulin resistance.16The Journal of Clinical Endocrinology & Metabolism. The Effect of Early Time-Restricted Eating vs Later Time-Restricted Eating on Weight Loss and Metabolic Health Since insulin resistance is a driver of both metabolic syndrome and atherosclerosis, the implication is that a morning-weighted eating window may do more for arterial health than a late-night one. For someone considering time-restricted eating for cardiovascular reasons, finishing the last meal by mid-afternoon appears to be a more potent strategy than simply compressing the eating window without regard to the clock.
The Gut Connection to Blood Pressure
One of the less obvious pathways by which fasting could affect arterial health runs through the gut. A study of patients with resistant hypertension, meaning their blood pressure stayed high despite three or more medications, found that intermittent fasting significantly reduced blood pressure and shifted the composition of their gut microbiota. The fasting group showed increases in bacterial species associated with gut-barrier integrity, along with lower levels of lipopolysaccharide (a bacterial toxin that triggers systemic inflammation) and TMAO, a gut-derived molecule linked to plaque instability and cardiovascular events. Short-chain fatty acids, which support gut-barrier health and have anti-inflammatory properties, increased.17PubMed. Intermittent fasting ameliorates resistant hypertension through modulation of gut microbiota Hypertension is one of the strongest accelerators of plaque growth and rupture, so achieving meaningful blood pressure reduction in treatment-resistant patients is a real cardiovascular win, even if plaque itself was not measured.
The Epidemiological Warning Signs
While most of the mechanistic and short-term trial evidence for fasting looks favorable, large observational studies have raised unsettling questions. An analysis of U.S. survey data presented at an American Heart Association conference found that people who regularly ate within a window of less than eight hours per day had roughly double the risk of dying from cardiovascular causes compared to those eating over twelve to sixteen hours.18Circulation. Abstract P192: Association Between Time-Restricted Eating and All-Cause and Cause-Specific Mortality A subsequent study using similar data confirmed this pattern, finding a cardiovascular mortality hazard ratio of about 2.35 for eating durations under eight hours, and noted that the association held across subgroups defined by race, socioeconomic status, and smoking.19PubMed. Association of eating duration less than 8 h with all-cause, cardiovascular, and cancer mortality
These findings generated headlines, but they come with serious caveats. They are observational, so they cannot prove that short eating windows caused the deaths. People who eat within very narrow windows may do so for reasons that independently raise their risk, such as irregular work schedules, underlying illness, or disordered eating. The dietary data relied on just two days of self-reported recall, which is a crude way to characterize a long-term eating pattern. And critically, this population was not practicing structured intermittent fasting; they were simply people who happened to eat within a short window. Still, until randomized trials with long follow-up address this question, the signal deserves attention rather than dismissal.
When Ketosis Itself Seems to Backfire
Fasting and ketogenic diets share a metabolic feature: both elevate ketone bodies, including BHB. The cell-culture evidence for BHB protecting blood vessel cells is encouraging, as described above, but a study of patients on long-term ketogenic diets for epilepsy treatment found that they had measurably thicker carotid artery walls than matched controls. The median carotid intima-media thickness was 0.62 mm versus 0.53 mm, a difference that grew with age.20PubMed Central. Carotid intima-media thickness may be an early biomarker for cardiovascular risk in patients treated with ketogenic dietary therapy Increased intima-media thickness is considered an early marker of atherosclerosis. The patients’ blood pressure, BMI, and blood lipids were within normal ranges, which makes the finding harder to explain away.
This does not mean fasting thickens arteries. The ketogenic diet for epilepsy is a specific, high-fat medical protocol maintained for years, which is very different from intermittent fasting. But it is a reminder that metabolic states involving elevated ketones are not automatically protective for arteries. Context, duration, and the overall dietary pattern all seem to modify whether ketosis helps or harms the vasculature.
Overall Cardiovascular Risk Versus Plaque Specifically
A systematic review of clinical trials examining fasting and cardiovascular disease concluded that fasting regimens are generally beneficial for lowering cardiovascular risk, a finding that held across different types of fasting protocols and was strongest when fasting was combined with regular exercise.21Cureus. The Effect of Fasting on Cardiovascular Diseases: A Systematic Review “Cardiovascular risk,” though, is a composite concept built from blood pressure, lipids, insulin sensitivity, body fat, and inflammation. Lowering those risk factors should logically slow plaque progression and might, over enough time, allow some regression. But the trials reviewed did not image arteries or measure plaque burden. The chain of reasoning from “improved risk factors” to “less plaque” has solid logic behind it but remains indirect.
The closest thing to direct human vascular evidence is the improvement in flow-mediated dilation seen with time-restricted eating in metabolic syndrome patients. That measurement reflects how well arteries dilate in response to increased blood flow, which deteriorates as plaque and endothelial dysfunction worsen. Improvement in that marker is reassuring, but it is not the same as watching plaque shrink on a CT scan or MRI. Until researchers design trials that image coronary or carotid arteries before and after a fasting intervention, the question in the title remains technically unanswered for humans.
What Would a Convincing Trial Look Like?
Researchers who study atherosclerosis regression with drugs like high-dose statins use serial coronary intravascular ultrasound or coronary CT angiography to measure plaque volume over twelve to twenty-four months. A fasting trial following the same playbook, randomizing people with established but stable coronary plaque to a well-defined intermittent fasting protocol versus standard dietary advice, with repeat imaging, would provide the kind of evidence that does not yet exist. The logistical hurdles are real: long-duration dietary compliance is hard to enforce and monitor, and imaging trials are expensive. But without that kind of study, the field is left inferring arterial outcomes from surrogate markers.
In the meantime, the biological plausibility is genuine. Fasting suppresses vascular inflammation, produces ketone bodies that protect endothelial cells, improves lipid profiles when done in moderate intermittent formats, lowers blood pressure even in resistant cases, and in at least one mouse model activated the very cleanup pathway that clears necrotic debris from plaques. The picture is also genuinely complicated by evidence that prolonged fasting spikes LDL, that some fasting protocols worsen atherosclerosis in mice, that very short eating windows correlate with higher cardiovascular mortality in observational data, and that sustained ketosis thickens carotid artery walls. Anyone telling you fasting definitely reverses plaque is getting ahead of the science. Anyone telling you it definitely cannot is ignoring what the mechanisms suggest is possible.